Prof. M. Nieuwdorp MD PhD publications

2021

• Scheithauer Torsten P. M., Bakker Guido J., Winkelmeijer Maaike, Davids Mark, Nieuwdorp Max, van Raalte Daniël H., Herrema Hilde Compensatory intestinal immunoglobulin response after vancomycin treatment in humans Gut microbes 2021;13 (1):1-14 [PubMed]
• de Groot Pieter, Nicolic Tanja, Pellegrini Silvia, Sordi Valeria, Imangaliyev Sultan, Rampanelli Elena, Hanssen Nordin, Attaye Ilias, Bakker Guido, Duinkerken Gaby, Joosten Annemarie, Prodan Andrei, Levin Evgeni, Levels Han, Potter van Loon Bartjan, van Bon Arianne, Brouwer Catherina, van Dam Sytze, Simsek Suat, van Raalte Daniel, Stam Frank, Gerdes Victor, Hoogma Roel, Diekman Martin, Gerding Martin, Rustemeijer Cees, de Bakker Bernadette, Hoekstra Joost, Zwinderman Aeilko, Bergman Jacques, Holleman Frits, Piemonti Lorenzo, de Vos Willem, Roep Bart, Nieuwdorp Max Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial Gut 2021;70 (1):92-105 [PubMed]
• Fuhri Snethlage Coco M., Nieuwdorp Max, Hanssen Nordin M. J. Faecal microbiota transplantation in endocrine diseases and obesity Best practice & research. Clinical endocrinology & metabolism 2021 [PubMed]
• ter Horst Kasper W., Vatner Daniel F., Zhang Dongyan, Cline Gary W., Ackermans Mariette T., Nederveen Aart J., Verheij Joanne, Demirkiran Ahmet, van Wagensveld Bart A., Dallinga-Thie Geesje M., Nieuwdorp Max, Romijn Johannes A., Shulman Gerald I., Serlie Mireille J. Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease Diabetes care 2021;44 (2):489-498 [PubMed]
• Balvers Manon, van den Born Bert-Jan H., Levin Evgeni, Nieuwdorp Max Impact drugs targeting cardiometabolic risk on the gut microbiota Current opinion in lipidology 2021;32 (1):38-54 [PubMed]
• Meijnikman Abraham S., Bruin Sjoerd, Groen Albert K., Nieuwdorp Max, Herrema Hilde Increased expression of key SARS-CoV-2 entry points in multiple tissues in individuals with NAFLD Journal of hepatology 2021;74 (3):748-749 [PubMed]
• van de Laar Arnold W. J. M., Gerdes Victor E. A., Huijgen Roeland, Acherman Yair I. Z., Meesters Eelco W., Nieuwdorp Max Interpretation of laboratory results after gastric bypass surgery: the effects of weight loss and time on 30 blood tests in a 5-year follow-up program Surgery for obesity and related diseases 2021;17 (2):319-328 [PubMed]
• Aron-Wisnewsky Judith, Warmbrunn Moritz V., Nieuwdorp Max, Clément Karine Metabolism and Metabolic Disorders and the Microbiome: The Intestinal Microbiota Associated With Obesity, Lipid Metabolism, and Metabolic Health—Pathophysiology and Therapeutic Strategies: The Intestinal Microbiota Associated With Obesity, Lipid Metabolism, and Metabolic Health: Pathophysiology and Therapeutic Strategies Gastroenterology 2021;160 (2):573-599 [PubMed]
• Nieuwdorp Max, Madsen Karen The Promise of Maintaining Diet-Induced Weight Loss by Swallowing One's Own Feces: Time to Provide a Do-It-Yourself Manual? Gastroenterology 2021;160 (1):17-19 [PubMed]

2020

• Attaye Ilias, Pinto-Sietsma Sara-Joan, Herrema Hilde, Nieuwdorp Max A Crucial Role for Diet in the Relationship between Gut Microbiota and Cardiometabolic Disease Annual review of medicine 2020;71:149-161 [PubMed]
• Verhaar Barbara J. H., Collard Didier, Prodan Andrei, Levels Johannes H. M., Zwinderman Aeilko H., Bäckhed Fredrik, Vogt Liffert, Peters Mike J. L., Muller Majon, Nieuwdorp Max, van den Born Bert-Jan H. Associations between gut microbiota, faecal short-chain fatty acids, and blood pressure across ethnic groups: the HELIUS study European heart journal 2020;41 (44):4259-4267 [PubMed]
• van Olden C. C., van de Laar A. W., Meijnikman A. S., Aydin O., van Olst N., Hoozemans J. B., de Brauw L. M., Bruin S. C., Acherman Y. I. Z., Verheij J., Pyykkö J. E., Hagedoorn M., Sanderman R., Bosma N. C., Tremaroli V., Lundqvist A., Olofsson L. E., Herrema H., Lappa D., Hjorth S., Nielsen J., Schwartz T., Groen A. K., Nieuwdorp M., Bäckhed F., Gerdes V. E. A. A systems biology approach to understand gut microbiota and host metabolism in morbid obesity: design of the BARIA Longitudinal Cohort Study Journal of internal medicine 2020 [PubMed]
• Husted Anna Sofie, Ekberg Jeppe H., Tripp Emma, Nissen Tinne A. D., Meijnikman Stijn, O'Brien Shannon L., Ulven Trond, Acherman Yair, Bruin Sjoerd C., Nieuwdorp Max, Gerhart-Hines Zach, Calebiro Davide, Dragsted Lars O., Schwartz Thue W. Autocrine negative feedback regulation of lipolysis through sensing of NEFAs by FFAR4/GPR120 in WAT Molecular metabolism 2020;42 [PubMed]
• Prodan Andrei, Tremaroli Valentina, Brolin Harald, Zwinderman Aeilko H., Nieuwdorp Max, Levin Evgeni Comparing bioinformatic pipelines for microbial 16S rRNA amplicon sequencing PLoS ONE 2020;15 (1):e0227434 [PubMed]
• Hartstra Annick V., de Groot Pieter F., Mendes Bastos Diogo, Levin Evgeni, Serlie Mireille J., Soeters Maarten R., Pekmez Ceyda T., Dragsted Lars O., Ackermans Mariette T., Groen Albert K., Nieuwdorp Max Correlation of plasma metabolites with glucose and lipid fluxes in human insulin resistance Obesity Science and Practice 2020;6 (3):340-349 [PubMed]
• Reeskamp Laurens F., Venema Andrea, Pereira Joao P. Belo, Levin Evgeni, Nieuwdorp Max, Groen Albert K., Defesche Joep C., Grefhorst Aldo, Henneman Peter, Hovingh G. Kees Differential DNA methylation in familial hypercholesterolemia EBioMedicine 2020;61 [PubMed]
• Meijnikman A. S., Aydin O., Prodan A., Tremaroli V., Herrema H., Levin E., Acherman Y., Bruin S., Gerdes V. E., Backhed F., Groen A. K., Nieuwdorp M. Distinct differences in gut microbial composition and functional potential from lean to morbidly obese subjects Journal of internal medicine 2020;288 (6):699-710 [PubMed]
• Witjes Julia J, Smits Loek P, Pekmez Ceyda T, Prodan Andrei, Meijnikman Abraham S, Troelstra Marian A, Bouter Kristien E C, Herrema Hilde, Levin Evgeni, Holleboom Adriaan G, Winkelmeijer Maaike, Beuers Ulrich H, van Lienden Krijn, Aron-Wisnewky Judith, Mannisto Ville, Bergman Jacques J, Runge Jurgen H, Nederveen Aart J, Dragsted Lars O, Konstanti Prokopis, Zoetendal Erwin G, de Vos Willem, Verheij Joanne, Groen Albert K, Nieuwdorp Max Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis Hepatology communications 2020;4 (11):1578-1590 [PubMed]
• van Lier Yannouck F., Davids Mark, Haverkate Nienke J. E., de Groot Pieter F., Donker Marjolein L., Meijer Ellen, Heubel-Moenen Floor C. J. I., Nur Erfan, Zeerleder Sacha S., Nieuwdorp Max, Blom Bianca, Hazenberg Mette D. Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients Science translational medicine 2020;12 (556) [PubMed]
• de Groot Pieter, Scheithauer Torsten, Bakker Guido J., Prodan Andrei, Levin Evgeni, Khan Muhammad Tanweer, Herrema Hilde, Ackermans Mariette, Serlie Mireille J. M., de Brauw Maurits, Levels Johannes H. M., Sales Amber, Gerdes Victor E., Ståhlman Marcus, Schimmel Alinda W. M., Dallinga-Thie Geesje, Bergman Jacques Jghm, Holleman Frits, Hoekstra Joost B. L., Groen Albert, Bäckhed Fredrik, Nieuwdorp Max Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time Gut 2020;69:502-512 [PubMed]
• Hartstra Annick V. Do you have the guts to be happy?: Role of the gut-brain axis and gut microbiota in human metabolism 2020. 239p. ISBN 9789464161519. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Nieuwdorp Max, Groen A. K.; Co-supervisors: Serlie Mireille J. M., Levin Evgeni)
• van Bommel E. J. M., Herrema H., Davids M., Kramer M. H. H., Nieuwdorp M., van Raalte D. H. Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: Results of a double-blind randomized trial in patients with type 2 diabetes Diabetes & metabolism 2020;46 (2):164-168 [PubMed]
• van Bommel Erik J. M., Smits Mark M., Ruiter Danique, Muskiet Marcel H. A., Kramer Mark H. H., Nieuwdorp Max, Touw Daan J., Heerspink Hiddo J. L., Joles Jaap A., van Raalte Daniël H. Effects of dapagliflozin and gliclazide on the cardiorenal axis in people with type 2 diabetes Journal of hypertension 2020;38 (9):1811-1819 [PubMed]
• van Baar Annieke C. G., Holleman Frits, Crenier Laurent, Haidry Rehan, Magee Cormac, Hopkins David, Rodriguez Grunert Leonardo, Galvao Neto Manoel, Vignolo Paulina, Hayee Bu'Hussain, Mertens Ann, Bisschops Raf, Tijssen Jan, Nieuwdorp Max, Guidone Caterina, Costamagna Guido, Devière Jacques, Bergman Jacques J. G. H. M. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: One year results from the first international, open-label, prospective, multicentre study Gut 2020;69 (2):295-303 [PubMed]
• Bakker Guido Joost J. Generating understanding in diabetes & obesity: The gut microbiota as a new player in metabolism 2020. 235p. ISBN 9789463614139. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Nieuwdorp Max, Groen A. K.; Co-supervisors: Herrema Hilde J., van Raalte Daniel H.)
• Aron-Wisnewsky Judith, Vigliotti Chloé, Witjes Julia, le Phuong, Holleboom Adriaan G., Verheij Joanne, Nieuwdorp Max, Clément Karine Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders Nature reviews. Gastroenterology & hepatology 2020;17 (5):279-297 [PubMed]
• Fenneman Aline C., Rampanelli Elena, Yin Yue S., Ames Jesse, Blaser Martin J., Fliers Eric, Nieuwdorp Max Gut microbiota and metabolites in the pathogenesis of endocrine disease Biochemical Society transactions 2020;48 (3):915-931 [PubMed]
• Warmbrunn Moritz V., Herrema Hilde, Aron-Wisnewsky Judith, Soeters Maarten R., van Raalte Daniel H., Nieuwdorp Max Gut microbiota: a promising target against cardiometabolic diseases Expert review of endocrinology and metabolism 2020;15 (1):13-27 [PubMed]
• Scheithauer Torsten P. M., Rampanelli Elena, Nieuwdorp Max, Vallance Bruce A., Verchere C. Bruce, van Raalte Daniël H., Herrema Hilde Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes Frontiers in immunology 2020;11 [PubMed]
• de Clercq Nicolien C. Gut microbiota in host metabolism and cancer: From biological pathways to novel treatment strategies 2020. 217p. ISBN 9789464190670. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Nieuwdorp Max, Romijn J. A.; Co-supervisors: van Laarhoven Hanneke W. M., Prodan A.)
• Verhaar Barbara J. H., Prodan Andrei, Nieuwdorp Max, Muller Majon Gut microbiota in hypertension and atherosclerosis: A review Nutrients 2020;12 (10):1-22 [PubMed]
• Gerdes Victor, Gueimonde Miguel, Pajunen Lotta, Nieuwdorp Max, Laitinen Kirsi How strong is the evidence that gut microbiota composition can be influenced by lifestyle interventions in a cardio-protective way? Atherosclerosis 2020;311:124-142 [PubMed]
• Hermes Gerben D. A., Reijnders Dorien, Kootte Ruud S., Goossens Gijs H., Smidt Hauke, Nieuwdorp Max, Blaak Ellen E., Zoetendal Erwin G. Individual and cohort-specific gut microbiota patterns associated with tissue-specific insulin sensitivity in overweight and obese males Scientific reports 2020;10 (1) [PubMed]
• Hartstra Annick V., Schüppel Valentina, Imangaliyev Sultan, Schrantee Anouk, Prodan Andrei, Collard Didier, Levin Evgeni, Dallinga-Thie Geesje, Ackermans Mariette T., Winkelmeijer Maaike, Havik Stefan R., Metwaly Amira, Lagkouvardos Ilias, Nier Anika, Bergheim Ina, Heikenwalder Mathias, Dunkel Andreas, Nederveen Aart J., Liebisch Gerhard, Mancano Giulia, Claus Sandrine P., Benítez-Páez Alfonso, la Fleur Susanne E., Bergman Jacques J., Gerdes Victor, Sanz Yolanda, Booij Jan, Kemper Elles, Groen Albert K., Serlie Mireille J., Haller Dirk, Nieuwdorp Max Infusion of donor feces affects the gut–brain axis in humans with metabolic syndrome Molecular metabolism 2020;42 [PubMed]
• van Bommel Erik J. M., Ruiter Danique, Muskiet Marcel H. A., van Baar Michaël J. B., Kramer Mark H. H., Nieuwdorp Max, Joles Jaap A., Bjornstad Petter, van Raalte Daniël H. Insulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults With Type 2 Diabetes and Preserved Renal Function Diabetes care 2020;43 (1):228-234 [PubMed]
• Bak Jessica C. G., Serné Erik H., Kramer Mark H. H., Nieuwdorp Max, Verheugt Carianne L. National diabetes registries: do they make a difference? Acta diabetologica 2020 [PubMed]
• Aron-Wisnewsky Judith, Warmbrunn Moritz V., Nieuwdorp Max, Clément Karine Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity? Gastroenterology 2020;158 (7):1881-1898 [PubMed]
• de Groot Pieter F., Nikolic Tatjana, Imangaliyev Sultan, Bekkering Siroon, Duinkerken Gaby, Keij Fleur M., Herrema Hilde, Winkelmeijer Maaike, Kroon Jeffrey, Levin Evgeni, Hutten Barbara, Kemper Elles M., Simsek Suat, Levels Johannes H. M., van Hoorn Flora A., Bindraban Renuka, Berkvens Alicia, Dallinga-Thie Geesje M., Davids Mark, Holleman Frits, Hoekstra Joost B. L., Stroes Erik S. G., Netea Mihai, van Raalte Daniël H., Roep Bart O., Nieuwdorp Max Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial Diabetologia 2020;63 (3):597-610 [PubMed]
• Meessen Emma C. E., Bakker Guido J., Nieuwdorp Max, Dallinga-Thie Geesje M., Kemper E. Marleen, Olde Damink Steven W., Romijn Johannes A., Hartmann Bolette, Holst Jens J., Knop Filip K., Groen Albert K., Schaap Frank G., Soeters Maarten R. Parenteral nutrition impairs plasma bile acid and gut hormone responses to mixed meal testing in lean healthy men Clinical nutrition (Edinburgh, Scotland) 2020 [PubMed]
• Koopen Annefleur M., de Clercq Nicolien C., Warmbrunn Moritz V., Herrema Hilde, Davids Mark, de Groot Pieter F., Kootte Ruud S., Bouter Kristien E. C., Nieuwdorp Max, Groen Albert K., Prodan Andrei Plasma metabolites related to peripheral and hepatic insulin sensitivity are not directly linked to gut microbiota composition Nutrients 2020;12 (8):1-12 [PubMed]
• van Bommel Erik J. M., Geurts Frank, Muskiet Marcel H. A., Post Adrian, Bakker Stephan J. L., Danser A. H. Jan, Touw Daan J., van Berkel Miranda, Kramer Mark H. H., Nieuwdorp Max, Ferrannini Ele, Joles Jaap A., Hoorn Ewout J., van Raalte Daniël H. SGLT2 inhibition versus sulfonylurea treatment effects on electrolyte and acid-base balance: secondary analysis of a clinical trial reaching glycemic equipoise: Tubular effects of SGLT2 inhibition in Type 2 diabetes Clinical science (London, England 2020;134 (23):3107-3118 [PubMed]
• Bouter Kristien E. C., van Bommel Erik J. M., Jansen Hans, van Harskamp Dewi, Schierbeek Henk, Ackermans Mariëtte T., Serlie Mireille J., Schimmel Alinda W. M., Nieuwdorp Max, Dallinga-Thie Geesje M., van Raalte Daniël H. The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well-controlled plasma LDL cholesterol Diabetes, obesity & metabolism 2020;22 (6):988-996 [PubMed]
• Wijdeveld Madelief, Nieuwdorp Max, IJzerman Richard The interaction between microbiome and host central nervous system: the gut-brain axis as a potential new therapeutic target in the treatment of obesity and cardiometabolic disease Expert opinion on therapeutic targets 2020;24 (7):639-653 [PubMed]
• van Bommel Erik J. M., Muskiet Marcel H. A., van Baar Michaël J. B., Tonneijck Lennart, Smits Mark M., Emanuel Anna L., Bozovic Andrea, Danser A. H. Jan, Geurts Frank, Hoorn Ewout J., Touw Daan J., Larsen Emil L., Poulsen Henrik E., Kramer Mark H. H., Nieuwdorp Max, Joles Jaap A., van Raalte Daniël H. The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial Kidney international 2020;97 (1):202-212 [PubMed]
• Houttu Veera, Boulund Ulrika, Grefhorst Aldo, Soeters Maarten R., Pinto-Sietsma Sara-Joan, Nieuwdorp Max, Holleboom Adriaan G. The role of the gut microbiome and exercise in non-alcoholic fatty liver disease Therapeutic advances in gastroenterology 2020;13 [PubMed]
• Gilijamse Pim W., Hartstra Annick V., Levin Evgeni, Wortelboer Koen, Serlie Mireille J., Ackermans Mariette T., Herrema Hilde, Nederveen Aart J., Imangaliyev Sultan, Aalvink Steven, Sommer Morton, Levels Han, Stroes Erik S. G., Groen Albert K., Kemper Marleen, de Vos Willem M., Nieuwdorp Max, Prodan Andrei Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose–response effects on glucose metabolism in human subjects with metabolic syndrome NPJ biofilms and microbiomes 2020;6 (1) [PubMed]

2019

• Katiraei Saeed, de Vries Margreet R., Costain Alice H., Thiem Kathrin, Hoving Lisa R., van Diepen Janna A., Smits Hermelijn H., Bouter Kristien E., Rensen Patrick C. N., Quax Paul H. A., Nieuwdorp Max, Netea Mihai G., de Vos Willem M., Cani Patrice D., Belzer Clara, van Dijk Ko Willems, Berbée Jimmy F. P., van Harmelen Vanessa Akkermansia muciniphila Exerts Lipid-Lowering and Immunomodulatory Effects without Affecting Neointima Formation in Hyperlipidemic APOE*3-Leiden.CETP Mice Molecular nutrition & food research 2019 [PubMed]
• Prodan Andrei, Levin Evgeni, Nieuwdorp Max Does disease start in the mouth, the gut or both?: Oral bacteria colonize the gut more frequently than previously thought eLife 2019;8 [PubMed]
• Stols-Gonçalves Daniela, Tristão Luca Schiliró, Henneman Peter, Nieuwdorp Max Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease Current diabetes reports 2019;19 (6):31 [PubMed]
• Aron-Wisnewsky Judith, Clément Karine, Nieuwdorp Max Fecal Microbiota Transplantation: a Future Therapeutic Option for Obesity/Diabetes? Current diabetes reports 2019;19 (8):51 [PubMed]
• Wortelboer Koen, Nieuwdorp Max, Herrema Hilde Fecal microbiota transplantation beyond Clostridioides difficile infections EBioMedicine 2019;44:716-729 [PubMed]
• Smits Loek P. From image to intervention: Innovation in cardiometabolic medicine 2019. 218p. ISBN 9789463803151. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Nieuwdorp M. , Nederveen A. J.; Co-supervisor: Coolen B. F.)
• Meessen Emma C. E., Warmbrunn Moritz V., Nieuwdorp Max, Soeters Maarten R. Human postprandial nutrient metabolism and low-grade inflammation: A narrative review Nutrients 2019;11 (12) [PubMed]
• Cammarota Giovanni, Ianiro Gianluca, Kelly Colleen R., Mullish Benjamin H., Allegretti Jessica R., Kassam Zain, Putignani Lorenza, Fischer Monika, Keller Josbert J., Costello Samuel Paul, Sokol Harry, Kump Patrizia, Satokari Reetta, Kahn Stacy A., Kao Dina, Arkkila Perttu, Kuijper Ed J., Vehreschild Maria J. G. T., Pintus Cristina, Lopetuso Loris, Masucci Luca, Scaldaferri Franco, Terveer E. M., Nieuwdorp Max, López-Sanromán Antonio, Kupcinskas Juozas, Hart Ailsa, Tilg Herbert, Gasbarrini Antonio International consensus conference on stool banking for faecal microbiota transplantation in clinical practice Gut 2019;68 (12):2111-2121 [PubMed]
• Nieuwdorp Max Looking for the start of metabolic disease in the gut Nature medicine 2019;25 (5):709 [PubMed]
• Surendran Ramya Preethi Molecular metabolism underlying hypertriglyceridemia: From bench to bedside 2019. 176p. ISBN 9789402814354. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Nieuwdorp M.; Co-supervisor: Dallinga-Thie G.)
• Stols-Gonçalves Daniela, Hovingh G. Kees, Nieuwdorp Max, Holleboom Adriaan G. NAFLD and Atherosclerosis: Two Sides of the Same Dysmetabolic Coin? Trends in endocrinology and metabolism: TEM 2019 [PubMed]
• Bakker Guido J., Schnitzler Johan G., Bekkering Siroon, de Clercq Nicolien C., Koopen Annefleur M., Hartstra Annick V., Meessen Emma C. E., Scheithauer Torsten P., Winkelmeijer Maaike, Dallinga-Thie Geesje M., Cani Patrice D., Kemper Elles Marleen, Soeters Maarten R., Kroon Jeffrey, Groen Albert K., van Raalte Daniël H., Herrema Hilde, Nieuwdorp Max Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjects Physiological reports 2019;7 (16) [PubMed]
• Deschasaux M. lanie, Zwinderman Koos, Nieuwdorp Max Origine ethnique et composition du microbiote intestinal Medecine sciences : M/S 2019;35 (5):401-404 [PubMed]
• Bakker Guido J, Vanbellinghen Manon C, Scheithauer Torsten P, Verchere C Bruce, Stroes Erik S, Timmers Nyanza K L M, Herrema Hilde, Nieuwdorp Max, Verberne Hein J, van Raalte Daniël H Pancreatic 18F-FDG uptake is increased in type 2 diabetes patients compared to non-diabetic controls PLoS ONE 2019;14 (3):e0213202 [PubMed]
• Bom Michiel J., Levin Evgeni, Driessen Roel S., Danad Ibrahim, Van Kuijk Cornelis C., van Rossum Albert C., Narula Jagat, Min James K., Leipsic Jonathon A., Belo Pereira João P., Taylor Charles A., Nieuwdorp Max, Raijmakers Pieter G., Koenig Wolfgang, Groen Albert K., Stroes Erik S.G., Knaapen Paul Predictive value of targeted proteomics for coronary plaque morphology in patients with suspected coronary artery disease EBioMedicine 2019;39:109-117 [PubMed]
• Prodan Andrei, Sommer Morten O. A., Nieuwdorp Max Rapid diagnosis of lung infections Nature biotechnology 2019;37 (7):725-726 [PubMed]
• Koopman Nienke, Molinaro Antonio, Nieuwdorp Max, Holleboom Adriaan G Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver disease Alimentary pharmacology & therapeutics 2019;50 (6):628-639 [PubMed]
• Scholtes Rosalie A., van Baar Michaël J. B., Lytvyn Yuliya, Bjornstad Petter, Nieuwdorp Max, Cherney David Z. I., van Raalte Daniël H. Sodium glucose cotransporter (SGLT)-2 inhibitors: Do we need them for glucose-lowering, for cardiorenal protection or both? Diabetes, obesity & metabolism 2019;21 (S2):24-33 [PubMed]
• Zhang Xiang, Nieuwdorp Max, Groen Albert K., Zwinderman Aeiko H. Statistical evaluation of diet-microbe associations BMC microbiology 2019;19 (1) [PubMed]
• van Mens T. E., Büller H. R., Nieuwdorp M. Targeted inhibition of gut microbiota proteins involved in TMAO production to reduce platelet aggregation and arterial thrombosis: a blueprint for drugging the microbiota in the treatment of cardiometabolic disease? Journal of thrombosis and haemostasis 2019;17 (1):3-5 [PubMed]
• Fluitman K. S., Nadar H. J., Roos D. S., Berendse H. W., Keijser B. J. F., Nieuwdorp M., Ijzerman R. G., Visser M. The Association of Olfactory Function with BMI, Appetite, and Prospective Weight Change in Dutch Community-Dwelling Older Adults journal of nutrition, health & aging 2019;23 (8):746-752 [PubMed]
• de Clercq Nicolien C., Frissen Myrthe N., Levin Evgeni, Davids Mark, Hartman Jorn, Prodan Andrei, Herrema H., Groen Albert K., Romijn Johannes A., Nieuwdorp Max The effect of having Christmas dinner with in-laws on gut microbiota composition Human Microbiome Journal 2019;13
• Muilwijk Mirthe, Nieuwdorp Max, Snijder Marieke B., Hof Michel H. P., Stronks Karien, van Valkengoed Irene G. M. The high risk for type 2 diabetes among ethnic minority populations is not explained by low-grade inflammation Scientific reports 2019;9 (1) [PubMed]
• Mohammed Yassene, Kootte Ruud S., Kopatz Wil F., Borchers Christoph H., Büller Harry R., Versteeg Henri H., Nieuwdorp Max, van Mens Thijs E. The intestinal microbiome potentially affects thrombin generation in human subjects Journal of thrombosis and haemostasis 2019 [PubMed]
• de Clercq Nicolien C., Frissen Myrthe N., Davids Mark, Groen Albert K., Nieuwdorp Max Weight Gain after Fecal Microbiota Transplantation in a Patient with Recurrent Underweight following Clinical Recovery from Anorexia Nervosa Psychotherapy and psychosomatics 2019;88 (1):58-60 [PubMed]

2018

• Surendran R. Preethi, Udayyapan Shanti D., Clemente-Postigo Mercedes, Havik Stefan R., Schimmel Alinda W. M., Tinahones Fransisco, Nieuwdorp Max, Dallinga-Thie Geesje M. Decreased GPIHBP1 protein levels in visceral adipose tissue partly underlie the hypertriglyceridemic phenotype in insulin resistance PLoS ONE 2018;13 (11) [PubMed]
• Deschasaux M. lanie, Bouter Kristien E., Prodan Andrei, Levin Evgeni, Groen Albert K., Herrema Hilde, Tremaroli Valentina, Bakker Guido J., Attaye Ilias, Pinto-Sietsma Sara-Joan, van Raalte Daniel H., Snijder Marieke B., Nicolaou Mary, Peters Ron, Zwinderman Aeilko H., Bäckhed Fredrik, Nieuwdorp Max Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography Nature medicine 2018;24 (10):1526-1531 [PubMed]
• Bouter K. E. C., Bakker G. J., Levin E., Hartstra A. V., Kootte R. S., Udayappan S. D., Katiraei S., Bahler L., Gilijamse P. W., Tremaroli V., Stahlman M., Holleman F., van Riel N. A. W., Verberne H. J., Romijn J. A., Dallinga-Thie G. M., Serlie M. J., Ackermans M. T., Kemper E. M., Willems van Dijk K., Backhed F., Groen A. K., Nieuwdorp M. Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects article Clinical and translational gastroenterology 2018;9 (5) [PubMed]
• Imangaliyev Sultan, Prodan Andrei, Nieuwdorp Max, Groen Albert K., van Riel Natal A. W., Levin Evgeni Domain intelligible models Methods (San Diego, Calif.) 2018;149:69-73 [PubMed]
• van Baar Annieke C. G., Prodan Andrei, Wahlgren Camilla D., Poulsen Steen S., Knop Filip K., Groen Albert K., Bergman Jacques J., Nieuwdorp Max, Levin Evgeni Duodenal L cell density correlates with features of metabolic syndrome and plasma metabolites Endocrine connections 2018;7 (5):673-680 [PubMed]
• Busch-Westbroek Tessa E., Delpeut Kamiel, Balm Ron, Bus Sicco A., Schepers Tim, Peters Edgar J., Smithuis Frank F., Maas Mario, Nieuwdorp Max Effect of Single Dose of RANKL Antibody Treatment on Acute Charcot Neuro-osteoarthropathy of the Foot Diabetes care 2018;41 (3):e21-e22 [PubMed]
• Smits Loek P., Kootte Ruud S., Levin Evgeni, Prodan Andrei, Fuentes Susana, Zoetendal Erwin G., Wang Zeneng, Levison Bruce S., Cleophas Maartje C. P., Kemper E. Marleen, Dallinga-Thie Geesje M., Groen Albert K., Joosten Leo A. B., Netea Mihai G., Stroes Erik S. G., de Vos Willem M., Hazen Stanley L., Nieuwdorp Max Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome Journal of the American Heart Association 2018;7 (7) [PubMed]
• Meijnikman Abraham S., Gerdes Victor E., Nieuwdorp Max, Herrema Hilde Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans Endocrine reviews 2018;39 (2):133-153 [PubMed]
• Singh Ramandeep, de Groot Pieter F., Geerlings Suzanne E., Hodiamont Caspar J., Belzer Clara, Berge Ineke J. M. Ten, de Vos Willem M., Bemelman Frederike J., Nieuwdorp Max Fecal microbiota transplantation against intestinal colonization by extended spectrum beta-lactamase producing Enterobacteriaceae: A proof of principle study ISRCTN48328635 ISRCTN BMC research notes 2018;11 (1) [PubMed]
• Udayappan Shantha D. Gut microbiota in relation to pathogenesis of obesity and type 2 diabetes 2018. 178p. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Stroes E. S. G., Nieuwdorp M.; Co-supervisors: Dallinga-Thie G. M., Herrema H. J.)
• Groen Robin N., de Clercq Nicolien C., Nieuwdorp Max, Hoenders H. J. Rogier, Groen Albert K. Gut microbiota, metabolism and psychopathology: A critical review and novel perspectives Critical reviews in clinical laboratory sciences 2018;55 (4):283-293 [PubMed]
• Emanuel Anna L., de Clercq Nicolien C., Koopen Annefleur M., van Poelgeest Erik, Serlie Mireille J. M., van Raalte Daniel H., Kramer Mark H. H., Nieuwdorp Max, Eringa Etto C., Serné Erik H. Iloprost infusion prevents the insulin-induced reduction in skeletal muscle microvascular blood volume but does not enhance peripheral glucose uptake in type 2 diabetic patients Diabetes, obesity & metabolism 2018;20 (11):2523-2531 [PubMed]
• Koh Ara, Molinaro Antonio, Ståhlman Marcus, Khan Muhammad Tanweer, Schmidt Caroline, Mannerås-Holm Louise, Wu Hao, Carreras Alba, Jeong Heeyoon, Olofsson Louise E., Bergh Per-Olof, Gerdes Victor, Hartstra Annick, de Brauw Maurits, Perkins Rosie, Nieuwdorp Max, Bergström G. ran, Bäckhed Fredrik Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1 Cell 2018;175 (4):947-961.e17 [PubMed]
• Fluitman Kristina S., Wijdeveld Madelief, Nieuwdorp Max, Ijzerman Richard G. Potential of butyrate to influence food intake in mice and men Gut 2018;67 (7):1203-1204 [PubMed]
• Schreuder Sanne M, Nieuwdorp M, Koelemay Marc J W, Bipat Shandra, Reekers Jim A Testing the sympathetic nervous system of the foot has a high predictive value for early amputation in patients with diabetes with a neuroischemic ulcer BMJ open diabetes research and care 2018;6 (1):e000592 [PubMed]
• van Baar A. C. G., Nieuwdorp M., Holleman F., Soeters M. R., Groen A. K., Bergman Jacques J. G. H. M. The Duodenum harbors a Broad Untapped Therapeutic Potential Gastroenterology 2018;154 (4):773-777 [PubMed]
• Aydin Ömrüm, Nieuwdorp Max, Gerdes Victor The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes Current diabetes reports 2018;18 (8) [PubMed]
• Kootte Ruud S. The role of the intestine in human glucose and lipid metabolism: Source for novel targets in the prevention of cardiometabolic disease 2018. ISBN 9789462339460. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Stroes E. S. G., Nieuwdorp M.; Co-supervisor: Dallinga-Thie G. M.)

2017

• Groen Albert K., Nieuwdorp Max An evaluation of the therapeutic potential of fecal microbiota transplantation to treat infectious and metabolic diseases EMBO molecular medicine 2017;9 (1):1-3 [PubMed]
• van Beurden Yvette H., De Groot Pieter F., van Nood Els, Nieuwdorp Max, Keller Josbert J., Goorhuis Abraham Complications, effectiveness, and long term follow-up of fecal microbiota transfer by nasoduodenal tube for treatment of recurrent Clostridium difficile infection United European gastroenterology journal 2017;5 (6):868-879 [PubMed]
• König J., Siebenhaar A., Högenauer C., Arkkila P., Nieuwdorp M., Norén T., Ponsioen C. Y., Rosien U., Rossen N. G., Satokari R., Stallmach A., de Vos W., Keller J., Brummer R. J. Consensus report: faecal microbiota transfer - clinical applications and procedures Alimentary pharmacology & therapeutics 2017;45 (2):222-239 [PubMed]
• van Beurden Yvette H., Nieuwdorp Max, van de Berg Pablo J. E. J., Mulder Chris J. J., Goorhuis Abraham Current challenges in the treatment of severe Clostridium difficile infection: early treatment potential of fecal microbiota transplantation Therapeutic advances in gastroenterology 2017;10 (4):373-381 [PubMed]
• De Groot Pieter F., Belzer Clara, Aydin Ömrüm, Levin Evgeni, Levels Johannes H., Aalvink Steven, Boot Fransje, Holleman Frits, van Raalte Daniël H., Scheithauer Torsten P., Simsek Suat, Schaap Frank G., Olde Damink Steven W. M., Roep Bart O., Hoekstra Joost B., de Vos Willem M., Nieuwdorp Max Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study PLoS ONE 2017;12 (12) [PubMed]
• Herrema Hilde, Ijzerman Richard G., Nieuwdorp Max Emerging role of intestinal microbiota and microbial metabolites in metabolic control Diabetologia 2017;60 (4):613-617 [PubMed]
• de Groot P. F., Frissen M. N., de Clercq N. C., Nieuwdorp M. Fecal microbiota transplantation in metabolic syndrome: History, present and future Gut microbes 2017;8 (3):253-267 [PubMed]
• Bakker Guido J., Nieuwdorp Max Fecal Microbiota Transplantation: Therapeutic Potential for a Multitude of Diseases beyond Clostridium difficile Microbiology spectrum 2017;5 (4) [PubMed]
• de Clercq Nicolien C., Frissen Myrthe N., Groen Albert K., Nieuwdorp Max Gut Microbiota and the Gut-Brain Axis: New Insights in the Pathophysiology of Metabolic Syndrome Psychosomatic medicine 2017;79 (8):874-879 [PubMed]
• ter Horst Kasper W., Gilijamse Pim W., Versteeg Ruth I., Ackermans Mariette T., Nederveen Aart J., la Fleur Susanne E., Romijn Johannes A., Nieuwdorp Max, Zhang Dongyan, Samuel Varman T., Vatner Daniel F., Petersen Kitt F., Shulman Gerald I., Serlie Mireille J. Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans Cell reports 2017;19 (10):1997-2004 [PubMed]
• Kootte Ruud S., Levin Evgeni, Salojärvi Jarkko, Smits Loek P., Hartstra Annick V., Udayappan Shanti D., Hermes Gerben, Bouter Kristien E., Koopen Annefleur M., Holst Jens J., Knop Filip K., Blaak Ellen E., Zhao Jing, Smidt Hauke, Harms Amy C., Hankemeijer Thomas, Bergman Jacques J. G. H. M., Romijn Hans A., Schaap Frank G., Olde Damink Steven W. M., Ackermans Mariette T., Dallinga-Thie Geesje M., Zoetendal Erwin, de Vos Willem M., Serlie Mireille J., Stroes Erik S. G., Groen Albert K., Nieuwdorp Max Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition Cell metabolism 2017;26 (4):611-619-e6 [PubMed]
• Udayappan Shanthadevi D., Kovatcheva-Datchary Petia, Bakker Guido J., Havik Stefan R., Herrema Hilde, Cani Patrice D., Bouter Kristien E., Belzer Clara, Witjes Julia J., Vrieze Anne, de Sonnaville Noor, Chaplin Alice, van Raalte Daniel H., Aalvink Steven, Dallinga-Thie Geesje M., Heilig Hans G. H. J., Bergström Göran, van der Meij Suzan, van Wagensveld Bart A., Hoekstra Joost B. L., Holleman Frits, Stroes Erik S. G., Groen Albert K., Bäckhed Fredrik, de Vos Willem M., Nieuwdorp Max Intestinal Ralstonia pickettii augments glucose intolerance in obesity PLoS ONE 2017;12 (11) [PubMed]
• ter Horst K. W., van Galen K. A., Gilijamse P. W., Hartstra A. V., de Groot P. F., van der Valk F. M., Ackermans M. T., Nieuwdorp M., Romijn J. A., Serlie M. J. Methods for quantifying adipose tissue insulin resistance in overweight/obese humans International journal of obesity (2005) 2017;41 (8):1288-1294 [PubMed]
• Schnitzler Johan G., Bernelot Moens Sophie J., Tiessens Feiko, Bakker Guido J., Dallinga-Thie Geesje M., Groen Albert K., Nieuwdorp Max, Stroes Erik S. G., Kroon Jeffrey Nile Red Quantifier: a novel and quantitative tool to study lipid accumulation in patient- derived circulating monocytes using confocal microscopy Journal of lipid research 2017;58 (11):2210-2219 [PubMed]
• ter Horst Kasper W. Obesity, ectopic lipids, and insulin resistance: Tissue-specific defects in nutrient handling 2017. 234p. ISBN 9789402806861. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Romijn J. A.; Co-supervisors: Serlie M. J. M., Nieuwdorp M.)
• Bouter Kristien E., van Raalte Daniël H., Groen Albert K., Nieuwdorp Max Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction Gastroenterology 2017;152 (7):1671-1678 [PubMed]
• ter Horst Kasper W., Gilijamse Pim W., Demirkiran Ahmet, van Wagensveld Bart A., Ackermans Mariette T., Verheij Joanne, Romijn Johannes A., Nieuwdorp Max, Maratos-Flier Eleftheria, Herman Mark A., Serlie Mireille J. The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans Molecular metabolism 2017;6 (11):1493-1502 [PubMed]

2016

• Smits Mark M., Tonneijck Lennart, Muskiet Marcel H. A., Hoekstra Trynke, Kramer Mark H. H., Diamant Michaela, Nieuwdorp Max, Groen Albert K., Cahen Djuna L., van Raalte Daniël H. Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients Diabetes, obesity & metabolism 2016;18 (12):1217-1225 [PubMed]
• Bernelot Moens Sophie J. Cardiovascular disease beyond traditional risk factors: Balancing lipids and inflammation 2016. 253p. ISBN 9789462334588. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Stroes E. S. G., Nieuwdorp M.; Co-supervisor: Dallinga-Thie G. M.)
• Bernelot Moens Sophie J., Stoekenbroek Robert M., van der Valk Fleur M., Verweij Simone L., Koelemay Mark J. W., Verberne Hein J., Nieuwdorp Max, Stroes Erik S. G. Carotid arterial wall inflammation in peripheral artery disease is augmented by type 2 diabetes: a cross-sectional study BMC cardiovascular disorders 2016;16 (1):237 [PubMed]
• Scheithauer Torsten P. M., Dallinga-Thie Geesje M., de Vos Willem M., Nieuwdorp Max, van Raalte Daniël H. Causality of small and large intestinal microbiota in weight regulation and insulin resistance Molecular metabolism 2016;5 (9):759-770 [PubMed]
• Li Simone S., Zhu Ana, Benes Vladimir, Costea Paul I., Hercog Rajna, Hildebrand Falk, Huerta-Cepas Jaime, Nieuwdorp Max, Salojärvi Jarkko, Voigt Anita Y., Zeller Georg, Sunagawa Shinichi, de Vos Willem M., Bork Peer Durable coexistence of donor and recipient strains after fecal microbiota transplantation Science 2016;352 (6285):586-589 [PubMed]
• van Rooijen Geeske, Denys Damiaan, Fliers Eric, Nieuwdorp Max Effective Electroconvulsive Therapy in a Patient With Psychotic Depression With Active Cushing Disease journal of ECT 2016;32 (3):e20-e21 [PubMed]
• Reijnders Dorien, Goossens Gijs H., Hermes Gerben D. A., Neis Evelien P. J. G., van der Beek Christina M., Most Jasper, Holst Jens J., Lenaerts Kaatje, Kootte Ruud S., Nieuwdorp Max, Groen Albert K., Olde Damink Steven W. M., Boekschoten Mark V., Smidt Hauke, Zoetendal Erwin G., Dejong Cornelis H. C., Blaak Ellen E. Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled Trial Cell metabolism 2016;24 (1):63-74 [PubMed]
• Reijnders Dorien, Goossens Gijs H., Hermes Gerben D. A., Neis Evelien P. J. G., van der Beek Christina M., Most Jasper, Holst Jens J., Lenaerts Kaatje, Kootte Ruud S., Nieuwdorp Max, Groen Albert K., Olde Damink Steven W. M., Boekschoten Mark V., Smidt Hauke, Zoetendal Erwin G., Dejong Cornelis H. C., Blaak Ellen E. Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled Trial Cell metabolism 2016;24 (2):341 [PubMed]
• de Clercq Nicolien C., Groen Albert K., Romijn Johannes A., Nieuwdorp Max Gut Microbiota in Obesity and Undernutrition Advances in nutrition 2016;7 (6):1080-1089 [PubMed]
• Koopen Annefleur M., Groen Albert K., Nieuwdorp Max Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk Current opinion in lipidology 2016;27 (6):615-622 [PubMed]
• ter Horst Kasper W., Gilijamse Pim W., Ackermans Mariette T., Soeters Maarten R., Nieuwdorp Max, Romijn Johannes A., Serlie Mireille J. Impaired insulin action in the liver, but not in adipose tissue or muscle, is a distinct metabolic feature of impaired fasting glucose in obese humans Metabolism: clinical and experimental 2016;65 (5):757-763 [PubMed]
• Hartstra A. V., Nieuwdorp M., Herrema H. Interplay between gut microbiota, its metabolites and human metabolism: Dissecting cause from consequence TRENDS IN FOOD SCIENCE & TECHNOLOGY 2016;57 (B):233-243
• Smits Loek P., Coolen Bram F., Panno Maria D., Runge Jurgen H., Nijhof Wouter H., Verheij Joanne, Nieuwdorp Max, Stoker Jaap, Beuers Ulrich H., Nederveen Aart J., Stroes Erik S. Noninvasive Differentiation between Hepatic Steatosis and Steatohepatitis with MR Imaging Enhanced with USPIOs in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study Radiology 2016;278 (3):782-791 [PubMed]
• Udayappan Shanthadevi, Manneras-Holm Louise, Chaplin-Scott Alice, Belzer Clara, Herrema Hilde, Dallinga-Thie Geesje M., Duncan Silvia H., Stroes Erik S. G., Groen Albert K., Flint Harry J., Backhed Fredrik, de Vos Willem M., Nieuwdorp Max Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice NPJ biofilms and microbiomes 2016;2:16009 [PubMed]
• van der Valk Fleur M., Bekkering Siroon, Kroon Jeffrey, Yeang Calvin, van den Bossche Jan, van Buul Jaap D., Ravandi Amir, Nederveen Aart J., Verberne Hein J., Scipione Corey, Nieuwdorp Max, Joosten Leo A. B., Netea Mihai G., Koschinsky Marlys L., Witztum Joseph L., Tsimikas Sotirios, Riksen Niels P., Stroes Erik S. G. Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans Circulation 2016;134 (8):611-624 [PubMed]
• Jakulj Lily, van Dijk Theo H., de Boer Jan Freark, Kootte Ruud S., Schonewille Marleen, Paalvast Yared, Boer Theo, Bloks Vincent W., Boverhof Renze, Nieuwdorp Max, Beuers Ulrich H. W., Stroes Erik S. G., Groen Albert K. Transintestinal Cholesterol Transport Is Active in Mice and Humans and Controls Ezetimibe-Induced Fecal Neutral Sterol Excretion Cell metabolism 2016;24 (6):783-794 [PubMed]
• van der Valk Fleur Translating lipid-driven infammation in atherosclerosis 2016. 273p. ISBN 9789462994188. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Stroes E. S. G., Nieuwdorp M.; Co-supervisor: Nederveen A. J.)

2015

• Witjes Julia J., van Raalte Daniel H., Nieuwdorp Max About the gut microbiome as a pharmacological target in atherosclerosis European journal of pharmacology 2015;763 (Part A):75-78 [PubMed]
• Melgar Silvia, Nieuwdorp Max Are Proton Pump Inhibitors Affecting Intestinal Microbiota Health? Gastroenterology 2015;149 (4):848-850 [PubMed]
• Mooij Hans L., Bernelot Moens Sophie J., Gordts Philip L. S. M., Stanford Kristin I., Foley Erin M., van den Boogert Marjolein A. W., Witjes Julia J., Hassing H. Carlijne, Tanck Michael W., van de Sande Michiel A. J., Levels J. Han, Kastelein John J. P., Stroes Erik S. G., Dallinga-Thie Geesje M., Esko Jeff D., Nieuwdorp Max Ext1 heterozygosity causes a modest effect on postprandial lipid clearance in humans Journal of lipid research 2015;56 (3):665-673 [PubMed]
• van Nood Elisabeth Fecal Microbiota Transplantation: Clinical and experimental studies 2015. 234p. ISBN 9789064648427. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Speelman P.; Co-supervisors: Keller J. J., Dijkgraaf M. G. W., Nieuwdorp M.)
• Mooij Hans Leonard Functional consequences of inborn and acquired errors in endothelial glycocalyx heparan sulfates 2015. 212p. ISBN 9789461825476. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Stroes E. S. G., Vink H.; Co-supervisors: Nieuwdorp M., Dallinga-Thie G. M.)
• Dallinga-Thie Geesje M., Nieuwdorp Max GLP1, an Important Regulator of Intestinal Lipid Metabolism Arteriosclerosis, thrombosis, and vascular biology 2015;35 (5):1048-1049 [PubMed]
• Bakker Guido J., Zhao Jing, Herrema Hilde, Nieuwdorp Max Gut Microbiota and Energy Expenditure in Health and Obesity Journal of clinical gastroenterology 2015;49 (Suppl. 1):S13-S19 [PubMed]
• Stoekenbroek R. M., Rensing K. L., Bernelot Moens S. J., Nieuwdorp M., DeVries J. H., Zwinderman A. H., Stroes E. S., Currie C. J., Hutten B. A. High daily insulin exposure in patients with type 2 diabetes is associated with increased risk of cardiovascular events Atherosclerosis 2015;240 (2):318-323 [PubMed]
• Hartstra Annick V., Bouter Kristien E. C., Bäckhed Fredrik, Nieuwdorp Max Insights into the role of the microbiome in obesity and type 2 diabetes Diabetes care 2015;38 (1):159-165 [PubMed]
• ter Horst K. W., Gilijamse P. W., Koopman K. E., de Weijer B. A., Brands M., Kootte R. S., Romijn J. A., Ackermans M. T., Nieuwdorp M., Soeters M. R., Serlie M. J. Insulin resistance in obesity can be reliably identified from fasting plasma insulin International journal of obesity (2005) 2015;39 (12):1703-1709 [PubMed]
• van der Valk Fleur M., van Wijk Diederik F., Lobatto Mark E., Verberne Hein J., Storm Gert, Willems Martine C. M., Legemate Dink A., Nederveen Aart J., Calcagno Claudia, Mani Venkatesh, Ramachandran Sarayu, Paridaans Maarten P. M., Otten Maarten J., Dallinga-Thie Geesje M., Fayad Zahi A., Nieuwdorp Max, Schulte Dominik M., Metselaar Josbert M., Mulder Willem J. M., Stroes Erik S. Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration Nanomedicine: nanotechnology, biology and medicine 2015;11 (5):1039-1046 [PubMed]
• Floch Martin H., Walker W. Allan, Sanders Mary Ellen, Nieuwdorp Max, Kim Adam S., Brenner David A., Qamar Amir A., Miloh Tamir A., Guarino Alfredo, Guslandi Mario, Dieleman Levinus A., Ringel Yehuda, Quigley Eamonn M. M., Brandt Lawrence J. Recommendations for Probiotic Use--2015 Update: Proceedings and Consensus Opinion Journal of clinical gastroenterology 2015;49 (Suppl. 1):S69-S73 [PubMed]
• van Olden Casper, Groen Albert K., Nieuwdorp Max Role of Intestinal Microbiome in Lipid and Glucose Metabolism in Diabetes Mellitus Clinical therapeutics 2015;37 (6):1172-1177 [PubMed]
• ter Horst Kasper W., Gilijamse Pim W., de Weijer Barbara A., Kilicarslan Murat, Ackermans Mariette T., Nederveen Aart J., Nieuwdorp Max, Romijn Johannes A., Serlie Mireille J. Sexual Dimorphism in Hepatic, Adipose Tissue, and Peripheral Tissue Insulin Sensitivity in Obese Humans Frontiers in endocrinology 2015;6:182 [PubMed]
• Lankelma J. M., Nieuwdorp M., de Vos W. M., Wiersinga W. J. The gut microbiota in internal medicine: implications for health and disease Netherlands journal of medicine 2015;73 (2):61-68 [PubMed]

2014

• Bernelot Moens Sophie J., Mooij Hans L., Hassing H. Carlijne, Kruit Janine K., Witjes Julia J., van de Sande Michiel A. J., Nederveen Aart J., Xu Ding, Dallinga-Thie Geesje M., Esko Jeffrey D., Stroes Erik S. G., Nieuwdorp Max Carriers of loss-of-function mutations in EXT display impaired pancreatic beta-cell reserve due to smaller pancreas volume PLoS ONE 2014;9 (12):e115662 [PubMed]
• Lankelma Jacqueline M., Nieuwdorp Max, de Vos Willem M., Wiersinga W. Joost De darmmicrobiota in gezondheid en ziekte Nederlands tijdschrift voor geneeskunde 2014;157:A5901 [PubMed]
• Singh R., van Nood E., Nieuwdorp M., van Dam B., ten Berge I. J. M., Geerlings S. E., Bemelman F. J. Donor feces infusion for eradication of Extended Spectrum beta-Lactamase producing Escherichia coli in a patient with end stage renal disease Clinical microbiology and infection 2014;20 (11):O977-O978 [PubMed]
• Nieuwdorp M. Faecal microbiota transplantation British journal of surgery 2014;101 (8):887-888 [PubMed]
• van Nood Els, Speelman Peter, Nieuwdorp Max, Keller Josbert Fecal microbiota transplantation: facts and controversies Current opinion in gastroenterology 2014;30 (1):34-39 [PubMed]
• Vrieze Anne, Out Carolien, Fuentes Susana, Jonker Lisanne, Reuling Isaie, Kootte Ruud S., van Nood Els, Holleman Frits, Knaapen Max, Romijn Johannes A., Soeters Maarten R., Blaak Ellen E., Dallinga-Thie Geesje M., Reijnders Dorien, Ackermans Mariette T., Serlie Mireille J., Knop Filip K., Holst Jenst J., van der Ley Claude, Kema Ido P., Zoetendal Erwin G., de Vos Willem M., Hoekstra Joost B. L., Stroes Erik S., Groen Albert K., Nieuwdorp Max Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity Journal of hepatology 2014;60 (4):824-831 [PubMed]
• Udayappan S. D., Hartstra A. V., Dallinga-Thie G. M., Nieuwdorp M. Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus Clinical and experimental immunology 2014;177 (1):24-29 [PubMed]
• van der Valk Fleur M., Kroon Jeffrey, Potters Wouter V., Thurlings Rogier M., Bennink Roelof J., Verberne Hein J., Nederveen Aart J., Nieuwdorp Max, Mulder Willem J. M., Fayad Zahi A., van Buul Jaap D., Stroes Erik S. G. In vivo imaging of enhanced leukocyte accumulation in atherosclerotic lesions in humans Journal of the American College of Cardiology 2014;64 (10):1019-1029 [PubMed]
• Mooij H. L., Cabrales P., Bernelot Moens S. J., Xu D., Udayappan S. D., Tsai A. G., van der Sande M. A. J., de Groot E., Intaglietta M., Kastelein J. J. P., Dallinga-Thie G. M., Esko J. D., Stroes E. S., Nieuwdorp M. Loss of function in heparan sulfate elongation genes EXT1 and EXT 2 results in improved nitric oxide bioavailability and endothelial function Journal of the American Heart Association 2014;3 (6):e001274 [PubMed]
• Samocha-Bonet D., Dixit V. D., Kahn C. R., Leibel R. L., Lin X., Nieuwdorp M., Pietiläinen K. H., Rabasa-Lhoret R., Roden M., Scherer P. E., Klein S., Ravussin E. Metabolically healthy and unhealthy obese - the 2013 Stock Conference report Obesity reviews 2014;15 (9):697-708 [PubMed]
• Khan Muhammad Tanweer, Nieuwdorp Max, Bäckhed Fredrik Microbial Modulation of Insulin Sensitivity Cell metabolism 2014;20 (5):753-760 [PubMed]
• Sanders Mary Ellen, Lenoir-Wijnkoop Irene, Salminen Seppo, Merenstein Daniel J., Gibson Glenn R., Petschow Bryon W., Nieuwdorp Max, Tancredi Daniel J., Cifelli Christopher J., Jacques Paul, Pot Bruno Probiotics and prebiotics: prospects for public health and nutritional recommendations Annals of the New York Academy of Sciences 2014;1309:19-29 [PubMed]
• Nieuwdorp Max, Gilijamse Pim W., Pai Nikhil, Kaplan Lee M. Role of the microbiome in energy regulation and metabolism Gastroenterology 2014;146 (6):1525-1533 [PubMed]
• Hassing H. Carlijne, Surendran R. Preethi, Derudas Bruno, Verrijken An, Francque Sven M., Mooij Hans L., Bernelot Moens Sophie J., Hart Leen M. 't, Nijpels Giel, Dekker Jacqueline M., Williams Kevin Jon, Stroes Erik S. G., van Gaal Luc F., Staels Bart, Nieuwdorp Max, Dallinga-Thie Geesje M. SULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus Obesity (Silver Spring, Md.) 2014;22 (5):1309-1316 [PubMed]
• van der Valk Fleur, Hassing Carlijne, Visser Maartje, Thakkar Purav, Mohanan Anookh, Pathak Kaushal, Dutt Chaitanya, Chauthaiwale Vijay, Ackermans Mariette, Nederveen Aart, Serlie Mireille, Nieuwdorp Max, Stroes Erik The effect of a diiodothyronine mimetic on insulin sensitivity in male cardiometabolic patients: a double-blind randomized controlled trial PLoS ONE 2014;9 (2):e86890 [PubMed]
• Fryer Lee G. D., Jones Bethan, Duncan Emma J., Hutchison Claire E., Ozkan Tozen, Williams Paul A., Alder Olivia, Nieuwdorp Max, Townley Anna K., Mensenkamp Arjen R., Stephens David J., Dallinga-Thie Geesje M., Shoulders Carol C. The endoplasmic reticulum coat protein II transport machinery coordinates cellular lipid secretion and cholesterol biosynthesis Journal of biological chemistry 2014;289 (7):4244-4261 [PubMed]
• Vinjé Sarah, Stroes Erik, Nieuwdorp Max, Hazen Stan L. The gut microbiome as novel cardio-metabolic target: the time has come! European heart journal 2014;35 (14):883-887 [PubMed]
• Singh R., Nieuwdorp M., ten Berge I. J. M., Bemelman F. J., Geerlings S. E. The potential beneficial role of faecal microbiota transplantation in diseases other than Clostridium difficile infection Clinical microbiology and infection 2014;20 (11):1119-1125 [PubMed]

2013

• van Nood Els, Vrieze Anne, Nieuwdorp Max, Fuentes Susana, Zoetendal Erwin G., de Vos Willem M., Visser Caroline E., Kuijper Ed J., Bartelsman Joep F. W. M., Tijssen Jan G. P., Speelman Peter, Dijkgraaf Marcel G. W., Keller Josbert J. Duodenal infusion of donor feces for recurrent Clostridium difficile New England journal of medicine 2013;368 (5):407-415 [PubMed]
• Vrieze A., de Groot P. F., Kootte R. S., Knaapen M., van Nood E., Nieuwdorp M. Fecal transplant: A safe and sustainable clinical therapy for restoring intestinal microbial balance in human disease? Best practice & research. Clinical gastroenterology 2013;27 (1):127-137 [PubMed]
• de Vos Willem M., Nieuwdorp Max Genomics: A gut prediction Nature 2013;498 (7452):48-49 [PubMed]
• Hassing H. Carlyne Glycobiology in cardiometabolic homeostasis 2013. 227p. ISBN 9789461917355. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Stroes E. S. G.; Co-supervisors: Nieuwdorp M., Dallinga-Thie G. M.)
• Bernelot Moens Sophie J., Hassing Carlijne H., Nieuwdorp Max, Stroes Erik S. G., Dallinga-Thie Geesje M. Hypertriglyceridemia: the future of genetics to guide individualized therapeutic strategies Clinical lipidology 2013;8 (3):321-328
• Sondermeijer Brigitte M., Battjes Suzanne, van Dijk Theo H., Ackermans Mariëtte T., Serlie Mireille J., Nieuwdorp Max, Groen Albert K., Dallinga-Thie Geesje M., Stroes Erik S. G. Lactate increases hepatic secretion of VLDL-triglycerides in humans Atherosclerosis 2013;228 (2):443-450 [PubMed]
• Mulders Ties A., Nieuwdorp Max, Stroes Erik S., Vink Hans, Pinto-Sietsma Sara-Joan Non-invasive assessment of microvascular dysfunction in families with premature coronary artery disease International journal of cardiology 2013;168 (5):5026-5028 [PubMed]
• Knaapen M., Kootte R. S., Zoetendal E. G., de Vos W. M., Dallinga-Thie G. M., Levi M. [=Marcel M.], Stroes E. S., Nieuwdorp M. Obesity, non-alcoholic fatty liver disease, and atherothrombosis: a role for the intestinal microbiota? Clinical microbiology and infection 2013;19 (4):331-337 [PubMed]
• Nieuwdorp Max, Vrieze Anne, de Vos Willem M. Reply to Konstantinov and Peppelenbosch Gastroenterology 2013;144 (4):e20-e21 [PubMed]
• Scicluna Brendon P., van 't Veer Cornelis, Nieuwdorp Max, Felsmann Karen, Wlotzka Britta, Stroes Erik S. G., van der Poll Tom Role of tumor necrosis factor-α in the human systemic endotoxin-induced transcriptome PLoS ONE 2013;8 (11):e79051 [PubMed]
• Scirica Benjamin M., Bhatt Deepak L., Braunwald Eugene, Steg P. Gabriel, Davidson Jaime, Hirshberg Boaz, Ohman Peter, Frederich Robert, Wiviott Stephen D., Hoffman Elaine B., Cavender Matthew A., Udell Jacob A., Desai Nihar R., Mosenzon Ofri, McGuire Darren K., Ray Kausik K., Leiter Lawrence A., Raz Itamar, Desai Nihar, Abrahamsen Timothy, Grossman Michelle, Morin Suzanne, Im KyungAh, Hoffman Elaine, Gabovitch Daniel, Pricken Alexandra, Buskila Alona, Stahre Christina, Price Deborah, Billing-Clason Solveig, Sabel Karin, Monyak John, Sjöstrand Mikalea, Wei Cheryl, Lu Jane, Miller Elinor, Raichlen Joel, Fitt Sandy, Iqbal Nayyar, Donovan Mark, Davidson Jaime A., Steg Ph Gabriel, Aguilar-Salinas Carlos, Alvarsson Michael, Amerena John, Ardissino Diego, Hoekstra Joost, Kastelein John, Wang J., Nieuwdorp M. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus New England journal of medicine 2013;369 (14):1317-1326 [PubMed]
• Smits Loek P., Bouter Kristien E. C., de Vos Willem M., Borody Thomas J., Nieuwdorp Max Therapeutic potential of fecal microbiota transplantation Gastroenterology 2013;145 (5):946-953 [PubMed]
• Vrieze Anne The role of gut microbiota in human metabolism 2013. 201p. ISBN 9789461084040. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Hoekstra J. B. L., de Vos W. M.; Co-supervisors: Nieuwdorp M., Holleman F.)

2012

• Vrieze Anne, Schopman Josefine E., Admiraal Wanda M., Soeters Maarten R., Nieuwdorp Max, Verberne Hein J., Holleman Frits Fasting and Postprandial Activity of Brown Adipose Tissue in Healthy Men Journal of nuclear medicine 2012;53 (9):1407-1410 [PubMed]
• Hassing H. Carlijne, Mooij Hans, Guo Shuling, Monia Brett P., Chen Keyang, Kulik Wim, Dallinga-Thie Geesje M., Nieuwdorp Max, Stroes Erik S. G., Williams Kevin Jon Inhibition of hepatic sulfatase-2 In Vivo: A novel strategy to correct diabetic dyslipidemia Hepatology (Baltimore, Md.) 2012;55 (6):1746-1753 [PubMed]
• Hassing H. C., Surendran R. P., Mooij H. L., Stroes E. S., Nieuwdorp M., Dallinga-Thie G. M. Pathophysiology of hypertriglyceridemia BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS 2012;1821 (5):826-832 [PubMed]
• Lemkes Bregtje A., Nieuwdorp Max, Hoekstra Joost B. L., Holleman Frits The Glycocalyx and Cardiovascular Disease in Diabetes: Should We Judge the Endothelium by Its Cover? Diabetes technology & therapeutics 2012;14 (1):S3-S10 [PubMed]
• Kootte R. S., Vrieze A., Holleman F., Dallinga-Thie G. M., Zoetendal E. G., de Vos W. M., Groen A. K., Hoekstra J. B. L., Stroes E. S., Nieuwdorp M. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus Diabetes, obesity & metabolism 2012;14 (2):112-120 [PubMed]
• Vrieze Anne, van Nood Els, Holleman Frits, Salojärvi Jarkko, Kootte Ruud S., Bartelsman Joep F. W. M., Dallinga-Thie Geesje M., Ackermans Mariette T., Serlie Mireille J., Oozeer Raish, Derrien Muriel, Druesne Anne, van Hylckama Vlieg Johan E. T., Bloks Vincent W., Groen Albert K., Heilig Hans G. H. J., Zoetendal Erwin G., Stroes Erik S., de Vos Willem M., Hoekstra Joost B. L., Nieuwdorp Max Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome Gastroenterology 2012;143 (4):913-+ [PubMed]

2011

• Broekhuizen Lysette N. Glycocalyx, cardiometabolic disease and inflammation 2011. 183p. ISBN 9789461082008. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Kastelein J. J. P., Vink H.; Co-supervisors: Stroes E. S. G., Nieuwdorp M.)
• Sivapalaratnam Suthesh, Farrugia Rosienne, Nieuwdorp Max, Langford Cordelia F., van Beem Rachel T., Maiwald Stephanie, Zwaginga Jaap Jan, Gusnanto Arief, Watkins Nicholas A., Trip Mieke D., Ouwehand Willem H. Identification of candidate genes linking systemic inflammation to atherosclerosis; results of a human in vivo LPS infusion study BMC medical genomics 2011;4:64 [PubMed]

2010

• van Sluis Geerte L., Nieuwdorp Max, Kamphuisen Pieter W., van der Vlag Johan, van Noorden Cornelis J. F., Spek C. Arnold A Low Molecular Weight Heparin Inhibits Experimental Metastasis in Mice Independently of the Endothelial Glycocalyx PLoS ONE 2010;5 (6):e11200 [PubMed]
• Broekhuizen L. N., Lemkes B. A., Mooij H. L., Meuwese M. C., Verberne H., Holleman F., Schlingemann R. O., Nieuwdorp M., Stroes E. S. G., Vink H. Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus Diabetologia 2010;53 (12):2646-2655 [PubMed]
• Meuwese Marijn C., Broekhuizen Lysette N., Kuikhoven Mayella, Heeneman Sylvia, Lutgens Esther, Gijbels Marion J. J., Nieuwdorp Max, Peutz Carine J., Stroes Erik S. G., Vink Hans, van den Berg Bernard M. Endothelial surface layer degradation by chronic hyaluronidase infusion induces proteinuria in apolipoprotein e-deficient mice PLoS ONE 2010;5 (12):e14262 [PubMed]
• Cherpanath T. G. V., Nieuwdorp M., Hazenberg M. D., van Eeden S., van der Sluijs A. F. Large nocturnal eyes causing gastrointestinal bleeding in asymptomatic multiple myeloma. CMV enterocolitis Netherlands journal of medicine 2010;68 (10):324-327 [PubMed]
• Vrieze A., Holleman F., Zoetendal E. G., de Vos W. M., Hoekstra J. B. L., Nieuwdorp M. The environment within: how gut microbiota may influence metabolism and body composition Diabetologia 2010;53 (4):606-613 [PubMed]
• Dallinga-Thie Geesje M., Franssen Remco, Mooij Hans L., Visser Maartje E., Hassing H. Carlijne, Peelman Frank, Kastelein John J. P., Péterfy Miklós, Nieuwdorp Max The metabolism of triglyceride-rich lipoproteins revisited: New players, new insight Atherosclerosis 2010;211 (1):1-8 [PubMed]

2009

• Broekhuizen Lysette N., Mooij Hans L., Kastelein John J. P., Stroes Eric S. G., Vink Hans, Nieuwdorp Max Endothelial glycocalyx as potential diagnostic and therapeutic target in cardiovascular disease Current opinion in lipidology 2009;20 (1):57-62 [PubMed]
• Nieuwdorp M., Nio C. Y., Bartelsman J. F. W. M., Hoekstra J. B. L. Intermitting umbilical pain, fever and weight loss in an otherwise healthy 65-year-old male Netherlands journal of medicine 2009;67 (8):334-335 [PubMed]
• Meuwese Marijn C., Mooij Hans L., Nieuwdorp Max, van Lith Bart, Marck Roos, Vink Hans, Kastelein John J. P., Stroes Erik S. G. Partial recovery of the endothelial glycocalyx upon rosuvastatin therapy in patients with heterozygous familial hypercholesterolemia Journal of lipid research 2009;50 (1):148-153 [PubMed]
• Verkleij Chantal J. N., Nieuwdorp Max, Gerdes Victor E. A., Mörgelin Matthias, Meijers Joost C. M., Marx Pauline F. The effects of hyperglycaemia on thrombin-activatable fibrinolysis inhibitor Thrombosis and haemostasis 2009;102 (3):460-468 [PubMed]
• Nieuwdorp M., Meuwese M. C., Mooij H. L., van Lieshout M. H. P., Hayden A., Levi M. [=Marcel M.], Meijers J. C. M., Ince C., Kastelein J. J. P., Vink H., Stroes E. S. G. Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbation Atherosclerosis 2009;202 (1):296-303 [PubMed]

2008

• Nieuwdorp M., van Nood E., Speelman P., van Heukelem H. A., Jansen J. M., Visser C. E., Kuijper E. J., Bartelsman J. F. W. M., Keller J. J. Behandeling van recidiverende Clostridium dificile-geassocieerde diarree met een suspensie van donorfeces Nederlands tijdschrift voor geneeskunde 2008;152 (35):1927-1932 [PubMed]
• Nieuwdorp Max, Meuwese Marijn C., Mooij Hans L., Ince Can, Broekhuizen Lysette N., Kastelein John J. P., Stroes Erik S. G., Vink Hans Measuring endothelial glycocalyx dimensions in humans: a potential novel tool to monitor vascular vulnerability Journal of applied physiology (Bethesda, Md. 2008;104 (3):845-852 [PubMed]
• Levi Marcel, Nieuwdorp Max, Poll Tom van der, Stroes Erik Metabolic modulation of inflammation-induced activation of coagulation Seminars in thrombosis and hemostasis 2008;34 (1):26-32 [PubMed]
• Nieuwdorp M., Vergeer M., Bisoendial R. J., Op 't Roodt J., Levels H., Birjmohun R. S., Kuivenhoven J. A., Basser R., Rabelink T. J., Kastelein J. J. P., Stroes E. S. G. Reconstituted HDL infusion restores endothelial function in patients with type 2 diabetes mellitus Diabetologia 2008;51 (6):1081-1084 [PubMed]
• van Beers Edward J., Nieuwdorp Max, Duits Ashley J., Evers Ludo M., Schnog John-John B., Biemond Bart J. Sickle cell patients are characterized by a reduced glycocalyx volume Haematologica 2008;93 (2):307-308 [PubMed]

2007

• Rana J. S., Nieuwdorp M., Jukema J. W., Kastelein J. J. P. Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart disease Diabetes, obesity & metabolism 2007;9 (3):218-232 [PubMed]
• van den Berg B. M., Nieuwdorp M., Stroes E. S. G., Vink H. Luminal Glycocalyx: protective barrier between endothelial cells and flowing blood.in: William C. Aird, editors. Endothelial Biomedicine. Cambridge: Cambridge University Press; 2007., ISBN 9780521853767
• Nieuwdorp M. Metabolic and vascular dysfunction during hyperglycemia induced inflammation. The role of the endothelial glycocalyx on vascular homeostasis in vivo 2007. 158p. ISBN 9789090221038. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Hoekstra Joost B. L., Kastelein John J. P.; Co-supervisors: Stroes Erik S. G., Vink Hans)
• Nieuwdorp M., Stroes E. S. G., Kastelein J. J. P. Normalization of metabolic syndrome using fenofibrate, metformin or their combination Diabetes, obesity & metabolism 2007;9 (6):869-878 [PubMed]
• Nieuwdorp M., Holleman F., de Groot E., Vink H., Gort J., Kontush A., Chapman M. J., Hutten B. A., Brouwer C. B., Hoekstra J. B. L., Kastelein J. J. P., Stroes E. S. G. Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis Diabetologia 2007;50 (6):1288-1293 [PubMed]
• van Oostrom O., Nieuwdorp M., Westerweel P. E., Hoefer I. E., Basser R., Stroes E. S. G., Verhaar M. C. Reconstituted HDL increases circulating endothelial progenitor cells in patients with type 2 diabetes Arteriosclerosis, thrombosis, and vascular biology 2007;27 (8):1864-1865 [PubMed]

2006

• Nieuwdorp Max, Mooij Hans L., Kroon Jojanneke, Atasever Bektas, Spaan Jos A. E., Ince Can, Holleman Frits, Diamant Michaela, Heine Robert J., Hoekstra Joost B. L., Kastelein John J. P., Stroes Erik S. G., Vink Hans Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes Diabetes 2006;55 (4):1127-1132 [PubMed]
• van den Berg Bernard M., Nieuwdorp Max, Stroes Erik S. G., Vink Hans Glycocalyx and endothelial (dys) function: from mice to men Pharmacological reports 2006;58 (Suppl):75-80 [PubMed]
• Nieuwdorp Max, van Haeften Timon W., Gouverneur Mirella C. L. G., Mooij Hans L., van Lieshout Miriam H. P., Levi Marcel, Meijers Joost C. M., Holleman Frits, Hoekstra Joost B. L., Vink Hans, Kastelein John J. P., Stroes Erik S. G. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo Diabetes 2006;55 (2):480-486 [PubMed]
• Rana Jamal S., Jansen Angelique C., Zwinderman Aeilko H., Nieuwdorp Max, van Aalst-Cohen Emily S., Jukema J. Wouter, Trip Mieke D., Kastelein John J. P. Metabolic syndrome and risk of coronary, cerebral, and peripheral vascular disease in a large Dutch population with familial hypercholesterolemia Diabetes care 2006;29 (5):1125-1127 [PubMed]
• Gouverneur M., Berg B., Nieuwdorp M., Stroes E., Vink H. Vasculoprotective properties of the endothelial glycocalyx: effects of fluid shear stress Journal of internal medicine 2006;259 (4):393-400 [PubMed]

2005

• Nieuwdorp Max, Stroes Erik S. G., Meijers Joost C. M., Büller Harry Hypercoagulability in the metabolic syndrome Current opinion in pharmacology 2005;5 (2):155-159 [PubMed]
• Nieuwdorp Max, Meuwese Marijn C., Vink Hans, Hoekstra Joost B. L., Kastelein John J. P., Stroes Erik S. G. The endothelial glycocalyx: a potential barrier between health and vascular disease Current opinion in lipidology 2005;16 (5):507-511 [PubMed]